Sustained upregulation of effector natural killer cells in chronic myeloid leukemia after discontinuation of imatinib-Reference-Cited by-同舟云学术

Sustained upregulation of effector natural killer cells in chronic myeloid leukemia after discontinuation of imatinib

Published:2013-07-09 Issue:9 Volume:104 Page:1146-1153
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Mizoguchi Izuru¹,Yoshimoto Takayuki¹,Katagiri Seiichiro²,Mizuguchi Junichiro³,Tauchi Tetsuzo²,Kimura Yukihiko²,Inokuchi Koiti⁴,Ohyashiki Junko H.⁵,Ohyashiki Kazuma²

Affiliation:

1. Department of Immunoregulation; Institute of Medical Science; Tokyo; Japan

2. Department of Hematology; Tokyo Medical University; Tokyo; Japan

3. Department of Immunology; Tokyo Medical University; Tokyo; Japan

4. Division of Hematology; Department of Internal Medicine; Nippon Medical School; Tokyo; Japan

5. Department of Molecular Oncology; Institute of Medical Science; Tokyo Medical University; Tokyo; Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.12216/fullpdf

Reference43 articles.

1. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells;Druker;Nat Med,1996

2. The molecular biology of chronic myeloid leukemia;Deininger;Blood,2000

3. International Randomized Study of Interferon vs STI571 (IRIS) 8-year follow up: sustained survival and low risk for progression or events in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) treated with imatinib;Deininger;Blood,2009

4. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet;Baccarani;Blood,2006

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging;Pharmaceutics;2023-03-11

2. A Single-cell Atlas Identifies Pretreatment Features of Primary Imatinib Resistance in Chronic Myeloid Leukemia;Blood;2023-03-01

3. Chemotherapy Effects on Immune System;Cancer Diagnostics and Therapeutics;2022

4. NK Cells in Myeloproliferative Neoplasms (MPN);Cancers;2021-08-31

5. Unleashing the power of NK cells in anticancer immunotherapy;Journal of Molecular Medicine;2021-08-09